An Alternating Irradiation Strategy-Driven Combination Therapy of PDT and RNAi for Highly Efficient Inhibition of Tumor Growth and Metastasis
- 1 April 2021
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (8), e2001850
- https://doi.org/10.1002/adhm.202001850
Abstract
Hypoxia and hypoxia induced overexpression of vascular endothelial growth factor (VEGF) not only seriously affects the treatment effects of photodynamic therapy (PDT) but also promotes tumor metastasis. Herein, an alternating irradiation strategy (referred to as alternate use of low/high dose of light [ALHDL] irradiation)-driven combination therapy of PDT and RNA interference (RNAi) is developed to synergistically inhibit tumor growth and metastasis. A cationic amphipathic peptide (ALS) served as a carrier in the co-delivery system of photochlor (HPPH) and siVEGF (ALSH/siVEGF). At the beginning of ALHDL-driven ALSH/siVEGF treatment, short-term LDL irradiation can facilitate the tumor penetration, cellular uptake, and endosome escape of ALSH/siVEGF. Moreover, accompanied by HDL-mediated rapid cell apoptosis and LDL-mediated efficient VEGF silencing, the joint use of PDT and RNAi achieved remarkable antitumor effects both in vitro and in vivo. Importantly, benefited from the excellent performance of ALHDL in slowing the rapid deterioration of the anoxic environment of tumors, and ALSH/siVEGF treatment-mediated highly improved VEGF silencing efficacy and inhibitory effect on angiogenesis, the liver and lung metastases of HeLa cells have been successfully suppressed. Together, this study clearly indicates that ALHDL-driven combination therapy of PDT and RNAi is a highly effective modality for inhibition of tumor growth and metastasis.Funding Information
- National Natural Science Foundation of China (51503131, 51703245, 81621003, 31771067)
- National Key Research and Development Program of China (2017YFC1103501)
- Natural Science Foundation of Jiangsu Province (BK20181377, BK20170733)
- Nanjing Tech University
This publication has 60 references indexed in Scilit:
- Components Simulation of Viral Envelope via Amino Acid Modified Chitosans for Efficient Nucleic Acid Delivery: In Vitro and In Vivo StudyAdvanced Functional Materials, 2012
- Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine–hyaluronic acid conjugateBiomaterials, 2010
- Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapyPhotochemical & Photobiological Sciences, 2009
- siRNA delivery systems for cancer treatmentAdvanced Drug Delivery Reviews, 2009
- Regulation of HSP70 on activating macrophages using PDT‐induced apoptotic cellsInternational Journal of Cancer, 2009
- Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic TherapyClinical Cancer Research, 2008
- The physics, biophysics and technology of photodynamic therapyPhysics in Medicine & Biology, 2008
- Fluence rate as a modulator of PDT mechanismsLasers in Surgery and Medicine, 2006
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Bcl-2 increases emptying of endoplasmic reticulum Ca2+ stores during photodynamic therapy-induced apoptosisCell Calcium, 2001